GlassScriptPhysician profile
John S Inman
NPI 1912991241
$2,801.98
in general payments reported to CMS, 2019-2025
39 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $210 · 2021: $372 · 2022: $557 · 2023: $589 · 2024: $310 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,245.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $457.49 | 2020-2025 | Wegovy, Saxenda |
| Astellas Pharma US INC | $448.91 | 2021-2025 | Veozah |
| Amgen INC. | $394.28 | 2019-2025 | Evenity |
| Abbvie INC. | $358.17 | 2019-2023 | |
| Pfizer INC. | $84.77 | 2021-2025 | |
| Lilly USA, LLC | $81.14 | 2021-2024 | Zepbound, Reyvow, Emgality |
| Ultragenyx Pharmaceutical INC. | $71.01 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $68.98 | 2022 | |
| Scilex Pharmaceuticals INC. | $67.95 | 2023 | Ztlido |
| Dexcom, INC. | $59.08 | 2024-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $58.85 | 2022-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Hologic Sales and Service, LLC | $54.10 | 2023 | Aptima, Panther Fusion |
| Exact Sciences Corporation | $50.36 | 2023-2024 | Cologuard Collection Kit |
| Corium, LLC | $38.92 | 2023-2024 | Azstarys |
| Bayer Healthcare Pharmaceuticals INC. | $38.60 | 2019-2024 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Inman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.